BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20441600)

  • 1. Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report).
    Dalhaug A; Haukland E; Nieder C
    World J Surg Oncol; 2010 May; 8():36. PubMed ID: 20441600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete cerebral response with sunitinib for metastatic renal cell carcinoma.
    Medioni J; Cojocarasu O; Belcaceres JL; Halimi P; Oudard S
    Ann Oncol; 2007 Jul; 18(7):1282-3. PubMed ID: 17675397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].
    Morizawa Y; Momose H; Toyoshima Y; Takada S; Fujimoto K; Oyama N
    Hinyokika Kiyo; 2013 Dec; 59(12):791-3. PubMed ID: 24419011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic collecting duct carcinoma of the kidney treated with sunitinib.
    Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
    World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
    Yoshinaga A; Kamata S
    Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Therapy for Renal Cell Carcinoma.
    Joshi R; Rawal S
    JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
    Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
    Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].
    Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M
    Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged response to cytoreductive surgery and sunitinib in an elderly patient with synchronous multiple metastases from renal cell carcinoma.
    Locatelli MC; Miedico A; D'Antona A; Longo G; Maggioni M; Maggioni A; Tombolini P; Tabiadon D
    Tumori; 2010; 96(3):478-82. PubMed ID: 20845812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature.
    Kusuda Y; Miyake H; Terakawa T; Furukawa J; Muramaki M; Fujisawa M
    Int J Urol; 2011 Apr; 18(4):326-9. PubMed ID: 25522450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastasis in renal cell cancer responding to sunitinib.
    Koutras AK; Krikelis D; Alexandrou N; Starakis I; Kalofonos HP
    Anticancer Res; 2007; 27(6C):4255-7. PubMed ID: 18214028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of actinic keratosis associated with sunitinib therapy for metastatic renal cell carcinoma.
    Mir-Bonafé JM; Cañueto J; Bravo J; de Unamuno P
    Int J Dermatol; 2013 Nov; 52(11):1445-7. PubMed ID: 23432117
    [No Abstract]   [Full Text] [Related]  

  • 13. Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature.
    Karaca H; Lale A; Dikilitas M; Ozkan M; Er O
    Med Oncol; 2010 Sep; 27(3):1023-6. PubMed ID: 19830602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report].
    Wang C; Takeda K; Shiba M; Takayama H; Munakata S
    Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy.
    Lim ZD; Mahajan A; Weinberg J; Tannir NM
    Am J Clin Oncol; 2013 Jun; 36(3):258-60. PubMed ID: 22441343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
    Michaelson MD; Iliopoulos O; McDermott DF; McGovern FJ; Harisinghani MG; Oliva E
    N Engl J Med; 2008 May; 358(22):2389-96. PubMed ID: 18509125
    [No Abstract]   [Full Text] [Related]  

  • 17. Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.
    Vaz MA; Pachón V; Grande E; Ferreiro R; Carrato A
    Anticancer Drugs; 2011 Sep; 22(8):817-21. PubMed ID: 21566523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report.
    Sbitti Y; Debbagh A; Slimani K; Mahi M; Errihani H; Ichou M
    J Med Case Rep; 2018 Mar; 12(1):80. PubMed ID: 29554941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
    J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
    [No Abstract]   [Full Text] [Related]  

  • 20. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
    Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH
    Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.